Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jan 2011

Gradilone A, Naso G, Raimondi C, Cortesi E, Gandini O, Vincenzi B, Saltarelli R, Chiapparino E, Spremberg F, Cristofanilli M, Frati L, Aglianò A M, Gazzaniga P

Abstract excerpt

BACKGROUND: the expression of ATP-binding cassette transporters on circulating tumor cells (CTCs) is predictive of response to chemotherapy in cancer patients. We tested the hypothesis that drug-resistant CTCs might have predictive value in metastatic breast cancer (MBC) and possibly retain stem-like properties. PATIENTS AND METHODS: CTCs obtained from 42 MBC patients were evaluated for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aldehyde Dehydrogenase
Share to Aldehyde Dehydrogenase 1 Family

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor alpha

Share to Isoenzymes

Share to Neoplasm Metastasis

Share to Neoplastic Cells, Circulating

Share to Receptor, ErbB-2

Share to Retinal Dehydrogenase

Source

Identifiers

PMID: 20603432
DOI: 10.1093/annonc/mdq323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.PMID 20603432Read ↗

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Semantic proximity Read ↗

Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.Semantic proximity Read ↗

Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.Semantic proximity Read ↗

Prognostic significance of a combined gene expression analysis in EpCAM(+) CTCs in metastatic breast cancer based on a long follow-upSemantic proximity Read ↗

The significance of circulating tumour cells in breast cancer: a review.Semantic proximity Read ↗

Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast CancerSemantic proximity Read ↗

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.Semantic proximity Read ↗

ATP binding cassette transporters and drug resistance in breast cancer.Semantic proximity Read ↗

Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients.Semantic proximity Read ↗

Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.Semantic proximity Read ↗

Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical valueSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.